Joel Greenblatt Roivant Sciences Ltd. Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 39,149 shares of ROIV stock, worth $828,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,149
Previous 39,027
0.31%
Holding current value
$828,784
Previous $393,000
12.21%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
364Shares Held
456MCall Options Held
8.56MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.27 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$946 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$822 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$749 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$725 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.9B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...